ERNEST BEUTLER, M.D.; KARL G. BLUME, M.D.
To the editor: In her editorial Dr. Bloomfield (1) very properly emphasizes the encouraging strides that have been made in the treatment of acute nonlymphocytic leukemia. It is true that 20 years ago treatment of such patients was a most discouraging experience. Today, as Dr. Bloomfield points out, chemotherapy has much more to offer. But we cannot agree with Dr. Bloomfield when she relegates to an experimental role bone marrow transplantation of patients in first remission. She suggests that such treatment might be acceptable only within the context of a controlled trial in which transplantation is being compared with chemotherapy.
BEUTLER E, BLUME KG. Marrow Transplantation and Acute Nonlymphocytic Leukemia. Ann Intern Med. ;93:778–780. doi: 10.7326/0003-4819-93-5-778
Download citation file:
Published: Ann Intern Med. 1980;93(5):778-780.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use